| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | United States | 5 | |
| #4 | Canada | 3 | |
| #5 | Australia | 2 | |
| #6 | Hungary | 1 | |
| #7 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Organic chemistry methods | |
| #5 | Special acyclic compounds | |
| #6 | Unspecified technologies | |
| #7 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | De Jong Marion | 9 |
| #2 | Krenning Eric Paul | 9 |
| #3 | Van Hagen Petrus Martinus | 6 |
| #4 | Maina-Nock Theodosia | 4 |
| #5 | Nock Berthold Artur | 4 |
| #6 | Srinivasan Ananthachari | 4 |
| #7 | Reubi Jean Claude | 3 |
| #8 | Maecke Helmut Robert | 3 |
| #9 | Ginj Mihaela | 3 |
| #10 | Rolleman Edgar | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2841238A1 | Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors | |
| EP1862172A1 | Combination of amino acid solution and a gelatin for inhibiting renal uptake | |
| US7122622B2 | Peptide compounds having improved binding affinity to somatostatin receptors | |
| EP1358890A1 | Benzothienyl analogue of somatostatine, selective for certain somatostatin receptors | |
| WO0220610A2 | Conformationally constrained labeled peptides for imaging and therapy | |
| CA2407514A1 | Rgd (arg-gly-asp) coupled to (neuro)peptides | |
| US6664367B1 | Stable analogs of bioactive peptides containing disulfide linkages |